ENTRY       D10845                      Drug
NAME        Conestat alfa (INN);
            Ruconest (TN)
PRODUCT     RUCONEST (Bioconnection B.V.)
            RUCONEST (Pharming Healthcare)
            RUCONEST (Tjoapack Netherlands BV)
SEQUENCE    NPNATSSSSQ DPESLQDRGE GKVATTVISK MLFVEPILEV SSLPTTNSTT NSATKITANT
            TDEPTTQPTT EPTTQPTIQP TQPTTQLPTD SPTQPTTGSF CPGPVTLCSD LESHSTEAVL
            GDALVDFSLK LYHAFSAMKK VETNMAFSPF SIASLLTQVL LGAGENTKTN LESILSYPKD
            FTCVHQALKG FTTKGVTSVS QIFHSPDLAI RDTFVNASRT LYSSSPRVLS NNSDANLELI
            NTWVAKNTNN KISRLLDSLP SDTRLVLLNA IYLSAKWKTT FDPKKTRMEP FHFKNSVIKV
            PMMNSKKYPV AHFIDQTLKA KVGQLQLSHN LSLVILVPQN LKHRLEDMEQ ALSPSVFKAI
            MEKLEMSKFQ PTLLTLPRIK VTTSQDMLSI MEKLEFFDFS YDLNLCGLTE DPDLQVSAMQ
            HQTVLELTET GVEAAAASAI SVARTLLVFE VQQPFLFVLW DQQHKFPVFM GRVYDPRA
            (Disulfide bridge: 101-406, 108-183)
  TYPE      Peptide
REMARK      ATC code: B06AC04
            Product: D10845<US>
EFFICACY    C1 esterase inhibitor
  DISEASE   Hereditary angioedema [DS:H01006]
COMMENT     Treatment of angioedemas, hereditary
TARGET      C1R [HSA:715] [KO:K01330]
            C1S [HSA:716] [KO:K01331]
            KLKB1 [HSA:3818] [KO:K01324]
  PATHWAY   hsa04610(3818+715+716)  Complement and coagulation cascades
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B06 OTHER HEMATOLOGICAL AGENTS
               B06A OTHER HEMATOLOGICAL AGENTS
                B06AC Drugs used in hereditary angioedema
                 B06AC04 Conestat alfa
                  D10845  Conestat alfa (INN) &lt;US&gt;
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Serine peptidases
                KLKB1
                 D10845  Conestat alfa (INN) &lt;US&gt;
                C1R
                 D10845  Conestat alfa (INN) &lt;US&gt;
                C1S
                 D10845  Conestat alfa (INN) &lt;US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10845
DBLINKS     CAS: 80295-38-1
            PubChem: 319902645
///
